Literature DB >> 32392329

Coordinated Action of miR-146a and Parkin Gene Regulate Rotenone-induced Neurodegeneration.

Abhishek Jauhari1,2,3, Tanisha Singh1,3, Saumya Mishra1,2, Jai Shankar1, Sanjay Yadav1,2,4.   

Abstract

Mitochondrial dysfunction is a common cause in pathophysiology of different neurodegenerative diseases. Elimination of dysfunctional and damaged mitochondria is a key requirement for maintaining homeostasis and bioenergetics of degenerating neurons. Using global microRNA (miRNA) profiling in a systemic rotenone model of Parkinson's disease, we have identified miR-146a as upmost-regulated miRNA, which is known as inflammation regulatory miRNA. Here, we report the role of activated nuclear factor kappa beta (NF-kβ) in miR-146a-mediated downregulation of Parkin protein, which inhibits clearance of damaged mitochondria and induces neurodegeneration. Our studies have shown that 4-week rotenone exposure (2.5 mg/kg b.wt) induced oxidative imbalance-mediated NF-kβ activation in 1-year-old rat's brain. Activated NF-kβ binds in promoter region of miR-146a gene and induces its transcription, which downregulates levels of Parkin protein. Decreased amount of Parkin protein results in accumulation of damaged and dysfunctional mitochondria, which further promotes the generation of reactive oxygen species in degenerating neurons. In conclusion, our studies have identified direct role of NF-kβ-mediated upregulation of miR-146a in regulating mitophagy through inhibition of the Parkin gene.
© The Author(s) 2020. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Parkin; miR-146a; mitochondria; mitophagy; neurodegeneration; rotenone

Year:  2020        PMID: 32392329     DOI: 10.1093/toxsci/kfaa066

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  8 in total

1.  Identification of Altered Blood MicroRNAs and Plasma Proteins in a Rat Model of Parkinson's Disease.

Authors:  Sanjeev Kumar Yadav; Anuj Pandey; Sana Sarkar; Smriti Singh Yadav; Devendra Parmar; Sanjay Yadav
Journal:  Mol Neurobiol       Date:  2022-01-13       Impact factor: 5.590

Review 2.  Parkinson's disease and microRNAs - Lessons from model organisms and human studies.

Authors:  Brian Evans; Howard A Furlong; Alexandre de Lencastre
Journal:  Exp Gerontol       Date:  2021-10-08       Impact factor: 4.032

Review 3.  An Emerging Role of miRNAs in Neurodegenerative Diseases: Mechanisms and Perspectives on miR146a.

Authors:  Navneet Ammal Kaidery; Manuj Ahuja; Sudarshana M Sharma; Bobby Thomas
Journal:  Antioxid Redox Signal       Date:  2021-02-15       Impact factor: 7.468

4.  NF-kB (p50/p65)-Mediated Pro-Inflammatory microRNA (miRNA) Signaling in Alzheimer's Disease (AD).

Authors:  Walter J Lukiw
Journal:  Front Mol Neurosci       Date:  2022-06-28       Impact factor: 6.261

Review 5.  The Role of Non-Coding RNAs in the Pathogenesis of Parkinson's Disease: Recent Advancement.

Authors:  Hanwen Zhang; Longping Yao; Zijian Zheng; Sumeyye Koc; Guohui Lu
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-30

6.  Enhanced Cognition and Neurogenesis in miR-146b Deficient Mice.

Authors:  Keerthana Chithanathan; Kelli Somelar; Monika Jürgenson; Tamara Žarkovskaja; Kapilraj Periyasamy; Ling Yan; Nathaniel Magilnick; Mark P Boldin; Ana Rebane; Li Tian; Alexander Zharkovsky
Journal:  Cells       Date:  2022-06-22       Impact factor: 7.666

Review 7.  Non-Coding RNAs in the Brain-Heart Axis: The Case of Parkinson's Disease.

Authors:  Shubhra Acharya; Antonio Salgado-Somoza; Francesca Maria Stefanizzi; Andrew I Lumley; Lu Zhang; Enrico Glaab; Patrick May; Yvan Devaux
Journal:  Int J Mol Sci       Date:  2020-09-06       Impact factor: 5.923

8.  Plasma hsa-mir-19b is a potential LevoDopa therapy marker.

Authors:  Aimee Rodica Chis; Alexandra Ioana Moatar; Cristina Dijmarescu; Cecilia Rosca; Ruxandra Julia Vorovenci; Inge Krabbendam; Amalia Dolga; Cristina Bejinar; Catalin Marian; Ioan Ovidiu Sirbu; Mihaela Simu
Journal:  J Cell Mol Med       Date:  2021-07-30       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.